Vaxcyte stock sinks despite Phase II IPD vaccine trial success

Vaxcyte stock sinks despite Phase II IPD vaccine trial success

Submitted by admin on April 1, 2025 - 11:38am
Source: 
Clinical Trials Arena
News Tags: 
Vaxcyte
pneumococcal disease
vaccines
clinical trials
Headline: 
Vaxcyte stock sinks despite Phase II IPD vaccine trial success
snippet: 

Vaxcyte’s stock has dropped around 45% despite a Phase II trial of its invasive pneumococcal disease (IPD) vaccine meeting all endpoints.

Do Not Allow Advertisers to Use My Personal information